Across pharmaceuticals, biotechnology, technology, consumer goods and private capital. Six have been acquired or sold to private equity.
01
Operating
Co-Founder
One of the world’s leading manufacturers of aseptic and terminally sterilized injectable medications. BPI set new standards in pharmaceutical production — the unglamorous manufacturing rigour that every therapy downstream quietly depends on.
02
FDA Approvals · Orphan Drug
Co-Founder
Pioneered novel therapeutics including a preservative-free Epinephrine and Ablysinol, an orphan drug for cardiac use. Belcher’s work is a study in finding the therapies nobody else would reformulate, and doing it properly.
03
Acquired · 4 Years
Founder
A biopharma company that reshaped the wound care market with proprietary sterilized Type II collagen dressings. Acquired within four years of inception.
Lark
04
Operating
Co-Founder
An industry leader in regenerative care, specialising in the development, manufacture and commercialisation of cell therapies and human cellular and tissue-based products — including perinatal mesenchymal stem cells (MSC) and exosomes.
05
FDA Approvals · Licensed Out
Founder
A CRO focused on the development of niche and novel therapeutics via the FDA 505(b)(2) regulatory pathway. Castun has been awarded several FDA approvals, since licensed off.
06
Operating
Co-Founder
A Brazil-based sterile injectable manufacturer of peptide-based products, sold directly to consumers and healthcare providers.
07
Operating
Founder
A pharmaceutical consultancy focused on the acquisition, licensing and sale of distressed and underperforming drug assets — value recovered from molecules other operators had written off.
08
Acquired · Private Equity
Co-Founder
One of the largest sterile 503A compounding pharmacies in the country, specialising in longevity, ophthalmics and animal health. Acquired by a private equity firm.
09
Sold · 5 Years
Co-Founder
A specialty generic pharmaceutical company commercialising niche therapeutics. Considered one of the fastest-growing generic pharmaceutical companies of its cohort, and sold to private equity within five years of inception.
10
Sold · 4 Years
Co-Founder
A GovTech business, and one of the first cloud-based SaaS public safety platforms — 911 dispatch and records management for agencies that had been running on decades-old systems. Sold to private equity within four years.
11
Operating
Co-Founder
An IT managed services provider covering infrastructure, co-location and virtual hosting. Ace is a leader in streaming services, AI, blockchain and crypto hosting.
12
Operating
Principal
A healthcare consultancy delivering solutions across pharmaceuticals, biotechnology and the medical sector. Its integrated approach combines science, technology and commercialisation to create sustainable value.
13
Operating
Family Owned
A family-owned vineyard in Napa Valley producing some of the most esteemed award-winning Cabernet Sauvignon in the valley.
14
IP Divested
Co-Founder
A bioscience company pioneering the use of Raman spectroscopy for the non-invasive testing of analytes. Kaligia created the first non-blood test for A1C and blood sugar; the intellectual property portfolio was subsequently divested.
15
Acquired · 3 Years
Founder
One of the largest contract manufacturers of nutraceutical and skincare products in the United States. Acquired within three years.
16
Acquired · 5 Years
Founder
A pioneer in the functional food space, BEN launched the first protein, zero-carbohydrate chip — a category that barely existed at the time. Acquired within five years.
17
NASDAQ Listed
Co-Founder
A NASDAQ-listed, multi-faceted healthcare company specialising in pharmaceutical contract manufacturing and pharmacy benefit management services.
18
Operating
Principal
A family office and diversified holding company dedicated to managing private capital and an investment portfolio spanning oil and gas, real estate, aircraft and sports entertainment.
Eighteen ventures. Founding and exit dates are not published for these companies.
